Increasing mixed chimerism (MC) after allogeneic stem cell transplantation (SCT) has been
associated with a high risk of relapse in acute leukemia. We evaluated a new method for …

Detection of increasing mixed chimerism (IMC) using standard PCR correlates with relapse
after allo-SCT for acute leukemias (ALs). Quantitative real-time PCR of insertion/deletion …

The role of chimerism analysis as a prognostic indicator of relapse after hematopoietic stem
cell transplantation (SCT) is controversial. We monitored chimerism status by short tandem …

Background The analysis of molecular haematopoietic chimerisms (HC) has become a well-
established method to monitor the transplant evolution and to assess the risk of relapse after …

Many congenital or acquired nonmalignant diseases (NMDs) of the hematopoietic system
can be potentially cured by allogeneic hematopoietic cell transplantation (HCT) with varying …

Relapse has become the major cause of treatment failure after allogeneic stem cell
transplantation. Outcome of patients with clinical relapse after transplantation generally …

Abstract Analysis of donor chimerism has become a routine method for the documentation of
engraftment after allogeneic hematopoietic stem cell transplantation (HSCT). In recent years …

Abstract Analysis of chimerism after allogeneic hematopoietic cell transplantation is
important for assessing engraftment and the early detection of graft failure. In addition, the …

Chimerism testing is used to monitor engraftment and risk of relapse after allogeneic
hematopoietic stem cell transplantation for hematologic malignancies. Although short …

Although improved donor sources and supportive care have decreased transplantation-
related mortality over the past decade, relapse remains the principal cause of failure after …